Abstract
Prostate cancer is the most frequently diagnosed malignancy in the Western male population and the associated socioeconomic impact on healthcare is of great concern. Since the early 1990s, MRI has evolved into an important diagnostic imaging modality for prostate cancer patients. In this review, the applications of diagnostic imaging modalities in prostate cancer, such as transrectal ultrasound, computed tomography and MRI are described. The clinical value of these techniques in prostate cancer detection, localization, characterization, staging and active surveillance are discussed.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.